Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women.

BACKGROUND The relative absence of coronary atherosclerosis in premenopausal women has been established. Estrogen is presumed to play a role in the protection of coronary arteries from atherosclerosis, and part of this protective effect appears to be mediated by amelioration of serum lipid profiles. However, all of the atheroprotective effect of estrogen is not explained by alteration of serum lipids. In this study, we attempt to identify evidence of estrogen receptors in coronary artery specimens of female patients and in human vascular smooth muscle cells. METHODS AND RESULTS Postmortem coronary artery specimens were obtained from premenopausal (n = 18) and postmenopausal (n = 22) women who died with significant coronary artery disease (n = 19) and from noncardiac causes with normal coronary arteries (n = 21). Sections were examined for evidence of estrogen receptor expression using a monoclonal antibody stain. Radioligand binding assays for estrogen receptors were performed on human vascular smooth muscle cells in culture, and gel retardation assays were performed to confirm the presence of functional estrogen receptors. Estrogen receptor expression was identified by immunostaining in a total of 21 coronary arteries, with the majority of normal arteries (15 positive of 21 total, P = .0117) demonstrating evidence of estrogen receptor expression. Conversely, a minority (6 of 19, P = NS) of atherosclerotic arteries were positive for estrogen receptor expression. Furthermore, the relation between estrogen receptor expression and absence of coronary atherosclerosis was most evident in premenopausal subjects, with 10 of 12 normal arteries in this group demonstrating evidence of estrogen receptors, whereas only 1 of 6 atherosclerotic coronary arteries was positive (P = .0062). Radioligand binding assays confirmed the presence of estrogen receptors at significant concentrations in intact human vascular smooth muscle cells. Gel retardation assays also documented the presence of functional estrogen receptors in extracts from human vascular smooth muscle cells. CONCLUSIONS This investigation provides evidence of estrogen receptors in smooth muscle cells from human coronary arteries. The demonstrated relation between the presence of the receptors and the absence of atherosclerosis in premenopausal women suggests that these receptors may play a functional role in coronary atheroprotection.

[1]  M. Legato Coronary artery disease in women. , 1996, International journal of fertility and menopausal studies.

[2]  A. Folsom,et al.  Association of Hormone-Replacement Therapy With Various Cardiovascular Risk Factors in Postmenopausal Women , 1993 .

[3]  D. Herrington,et al.  Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. , 1992, Journal of the American College of Cardiology.

[4]  K. Matthews,et al.  Menopause and risk factors for coronary heart disease. , 1990, The New England journal of medicine.

[5]  H. S. Klopfenstein,et al.  Estrogen modulates responses of atherosclerotic coronary arteries. , 1990, Circulation.

[6]  K. Matthews,et al.  Menopause and Risk Factors for Coronary Heart Disease , 1989 .

[7]  O. Hiort,et al.  Immunohistochemistry of estrogen receptor protein in paraffin sections. Effects of enzymatic pretreatment and cobalt chloride intensification. , 1988, American journal of clinical pathology.

[8]  P. Chambon,et al.  The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer , 1988, Cell.

[9]  R. Knopp,et al.  Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. , 1988, American journal of obstetrics and gynecology.

[10]  J. Barboriak,et al.  Postmenopausal use of estrogen and occlusion of coronary arteries. , 1988, American heart journal.

[11]  T. Clarkson,et al.  Pregnancy‐Associated Inhibition of Coronary Artery Atherosclerosis in Monkeys: Evidence of a Relationship with Endogenous Estrogen , 1987, Arteriosclerosis.

[12]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[13]  J. Said,et al.  Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction. , 1987, American journal of clinical pathology.

[14]  P. Ramwell,et al.  Endothelium-dependent gender differences in the response of the rat aorta. , 1987, The Journal of pharmacology and experimental therapeutics.

[15]  B. Katzenellenbogen,et al.  Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[16]  U. Stenman,et al.  Variation of postheparin plasma hepatic lipase by menstrual cycle. , 1986, Metabolism: clinical and experimental.

[17]  C. Olsson,et al.  Steroid effects on protein synthesis in cultured smooth muscle cells from rat aorta. , 1983, Endocrinology.

[18]  E. Nikkilä,et al.  High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. , 1982, The Journal of clinical endocrinology and metabolism.

[19]  K. Horwitz,et al.  Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. , 1982, The Journal of clinical investigation.

[20]  D. Harder,et al.  Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle , 1979, Journal of cellular physiology.

[21]  P. Colburn Estrogen‐Binding Sites in Endothelial Cell Cultures , 1979, Science.

[22]  G. M. Fischer,et al.  Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. , 1977, The American journal of physiology.

[23]  W. McGuire,et al.  MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors , 1975, Steroids.

[24]  H. Wolinsky Effects of Estrogen and Progestogen Treatment on the Response of the Aorta of Male Rats to Hypertension: MORPHOLOGICAL AND CHEMICAL STUDIES , 1972, Circulation research.

[25]  E. Reed,et al.  Gonadal Function and the Development of Coronary Heart Disease , 1963, Circulation.

[26]  T. J. Williams,et al.  Autopsy comparison of cardiovascular changes in castrated and normal women. , 1960, American journal of obstetrics and gynecology.

[27]  R. W. Robinson,et al.  Increased incidence of coronary heart disease in women castrated prior to the menopause. , 1959, Archives of internal medicine.

[28]  G. S. Boyd,et al.  Effect of bilateral ovariectomy on coronary-artery disease and serum-lipid levels. , 1959, Lancet.

[29]  S. Dimitroff,et al.  The Incidence and Severity of Atherosclerosis in Estrogen‐Treated Males, and in Females with a Hypoestrogenic or a Hyperestrogenic State , 1954, Circulation.

[30]  J. Edwards,et al.  The Degree of Coronary Atherosclerosis in Bilaterally Oophorectomized Women , 1953, Circulation.

[31]  J. Stamler,et al.  Prevention of Coronary Atherosclerosis by Estrogen‐Androgen Administration in the Cholesterol‐Fed Chick , 1953, Circulation research.

[32]  J. Stamler,et al.  Estrogen‐Induced Regression of Coronary Atherosclerosis in Cholesterol‐Fed Chicks , 1952, Circulation.

[33]  J. Stamler,et al.  The Inhibition of Coronary Atherosclerosis by Estrogens in Cholesterol‐Fed Chicks , 1952, Circulation.

[34]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[35]  B. Clawson Incidence of types of heart disease among 30,265 autopsies, with special reference to age and sex , 1941 .

[36]  A. Master,et al.  AGE, SEX AND HYPERTENSION IN MYOCARDIAL INFARCTION DUE TO CORONARY OCCLUSION , 1939 .

[37]  P. White,et al.  CORONARY DISEASE IN YOUTH: COMPARISON OF 100 PATIENTS UNDER 40 WITH 300 PERSONS PAST 80 , 1937 .

[38]  H. Mcgill,et al.  Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp.). , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[39]  S. Murota,et al.  Estradiol-binding sites in rat aortic smooth muscle cells in culture. , 1981, Atherosclerosis.

[40]  Meirelles Rs,et al.  Vasodilating Effect of Estrogen on the Human Umbilical Artery , 1977 .

[41]  S. R. Reynolds,et al.  PERIPHERAL VASCULAR ACTION OF ESTROGEN, OBSERVED IN THE EAR OF THE RABBIT , 1940 .